Integrated molecular dissection of the epidermal growth factor receptor (EFGR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer

By Sartore-Bianchi Andrea  

Targeted Oncology, Vol. 5, Iss. 1, 2010-03 ,pp. : 19-28

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

By Tsutsui S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 1, 2002-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Serum and Correspondent Tissue Measurements of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGF-R): Clinical Relevance in Pancreatic Cancer and Chronic Pancreatitis

By  

International Journal of Gastrointestinal Cancer, Vol. 25, Iss. 2, 1999-04 ,pp. : 89-96

Humana Press, Inc

Access to resources Recommend Favorite

Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases

By McKay J.A.   Murray L.J.   Curran S.   Ross V.G.   Clark C.   Murray G.I.   Cassidy J.   McLeod H.L.  

European Journal of Cancer, Vol. 38, Iss. 17, 2002-11 ,pp. : 2258-2264

Elsevier

Access to resources Recommend Favorite

Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma

By Lu Rong-li   Hu Cheng-Ping   Yang Hua-ping   Li Yuan-yuan   Gu Qi-hua   Wu Lielin  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 445-451

Springer Publishing Company

Access to resources Recommend Favorite